Preparation of 4-benzimidazolyl-2-morpholino-6-piperidinyl-4-pyrimidine derivatives as PI3K and mTOR kinase inhibitors for the treatment of proliferative disorder
Chloe Atkinson2017-11-07T15:54:21+00:0011. Preparation of 4-benzimidazolyl-2-morpholino-6-piperidinyl-4-pyrimidine derivatives as PI3K and mTOR kinase inhibitors for the treatment of proliferative disorder Butterworth, Sam; Griffen, Edward Jolyon; Hill, George Beresford; Pass, Martin WO 2008032089 A1.